Filled for bankruptcy in Oct 2023
RMED - Ra Medical Systems, Inc.
NYSE
->
Healthcare
->
Medical Devices
Carlsbad,
United States
Type: Equity
RMED price evolution
RMED
| (in millions $) | 31 Mar 2023 | 31 Jan 2023 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $12.22 | $15.86 | $13.66 | $11.13 |
| Short term investments | ||||
| Net receivables | $0.08 | $0.02 | ||
| Inventory | $0.07 | $0.04 | ||
| Total current assets | $12.76 | $16.84 | $15.54 | $12.33 |
| Long term investments | ||||
| Property, plant & equipment | $0.18 | $1.89 | $2 | |
| Goodwill & intangible assets | $35.56 | |||
| Total noncurrent assets | $35.75 | $1.93 | $2.04 | |
| Total investments | ||||
| Total assets | $48.51 | $16.84 | $17.47 | $14.37 |
| Current liabilities | ||||
| Accounts payable | $8.69 | $0.09 | $0.46 | $0.49 |
| Deferred revenue | ||||
| Short long term debt | $0.05 | $0.31 | $0.3 | |
| Total current liabilities | $4.45 | $7.58 | $3.21 | $2.75 |
| Long term debt | $0.09 | $1.75 | $1.83 | |
| Total noncurrent liabilities | $8.19 | $1.75 | $1.83 | |
| Total debt | $0.14 | $2.05 | $2.13 | |
| Total liabilities | $12.65 | $7.58 | $4.96 | $4.58 |
| Shareholders' equity | ||||
| Retained earnings | -$271.54 | -$205.14 | -$196.98 | -$192.22 |
| Other shareholder equity | -$0 | -$0 | -$0 | |
| Total shareholder equity | $35.86 | $9.26 | $12.51 | $9.79 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $15.86 | $15.04 | $23.91 | $14.58 |
| Short term investments | $15.99 | |||
| Net receivables | $0.02 | $0.24 | $0.79 | |
| Inventory | $0.99 | $2.22 | $2.78 | |
| Total current assets | $16.84 | $17.09 | $27.62 | $36 |
| Long term investments | ||||
| Property, plant & equipment | $3.92 | $5.7 | $7.88 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $3.96 | $5.82 | $8.08 | |
| Total investments | $15.99 | |||
| Total assets | $16.84 | $21.04 | $33.44 | $44.08 |
| Current liabilities | ||||
| Accounts payable | $0.09 | $0.99 | $0.57 | $1.53 |
| Deferred revenue | $2.49 | $3.26 | ||
| Short long term debt | $0.28 | $1.04 | $0.61 | |
| Total current liabilities | $7.58 | $5.39 | $7.76 | $6.81 |
| Long term debt | $1.98 | $3.84 | $2.88 | |
| Total noncurrent liabilities | $1.98 | $4.53 | $4.12 | |
| Total debt | $2.26 | $4.88 | $3.5 | |
| Total liabilities | $7.58 | $7.37 | $12.29 | $10.93 |
| Shareholders' equity | ||||
| Retained earnings | -$205.14 | -$178.27 | -$153.2 | -$117.16 |
| Other shareholder equity | -$0 | $0.03 | ||
| Total shareholder equity | $9.26 | $13.67 | $21.15 | $33.15 |
| (in millions $) | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.09 | $0.01 | ||
| Cost of revenue | $0.01 | $0.07 | ||
| Gross Profit | $0.07 | -$0.06 | ||
| Operating activities | ||||
| Research & development | $0.24 | $0.15 | $0.73 | $2.4 |
| Selling, general & administrative | $10.23 | $7.96 | $3.51 | $2.48 |
| Total operating expenses | $66.56 | $8.21 | $4.78 | $8.4 |
| Operating income | -$66.48 | -$8.21 | -$4.78 | -$8.46 |
| Income from continuing operations | ||||
| EBIT | -$66.4 | -$8.16 | -$4.76 | -$8.45 |
| Income tax expense | $0 | |||
| Interest expense | ||||
| Net income | ||||
| Net income | -$66.4 | -$8.16 | -$4.76 | -$8.45 |
| Income (for common shares) | -$67.2 | -$8.16 | -$4.76 | -$8.45 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.01 | $0.02 | $4.41 | $7.2 |
| Cost of revenue | $0.16 | $1.56 | $5.48 | $8.85 |
| Gross Profit | -$0.15 | -$1.54 | -$1.08 | -$1.65 |
| Operating activities | ||||
| Research & development | $6.39 | $12.25 | $9.01 | $4.53 |
| Selling, general & administrative | $16.25 | $15.47 | $25.97 | $51.55 |
| Total operating expenses | $26.81 | $27.73 | $34.98 | $56.08 |
| Operating income | -$26.96 | -$29.27 | -$36.06 | -$57.73 |
| Income from continuing operations | ||||
| EBIT | -$26.86 | -$25.07 | -$35.93 | -$56.69 |
| Income tax expense | $0 | $0 | $0.01 | $0.01 |
| Interest expense | $0.11 | $0.25 | ||
| Net income | ||||
| Net income | -$26.86 | -$25.07 | -$36.05 | -$56.96 |
| Income (for common shares) | -$26.86 | -$25.07 | -$36.05 | -$56.96 |
| (in millions $) | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Net income | -$66.4 | -$8.16 | -$4.76 | -$8.45 |
| Operating activities | ||||
| Depreciation | $1.44 | $0.03 | $0.07 | $0.14 |
| Business acquisitions & disposals | $0.01 | |||
| Stock-based compensation | $1.39 | $0.08 | $0.07 | $0.13 |
| Total cash flows from operations | -$12.05 | -$3.02 | -$4.97 | -$6.01 |
| Investing activities | ||||
| Capital expenditures | -$0.04 | $0.02 | ||
| Investments | ||||
| Total cash flows from investing | -$0.02 | $0.02 | ||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $9.51 | $5.2 | $7.5 | -$0.52 |
| Net borrowings | -$0.25 | |||
| Total cash flows from financing | $8.43 | $5.21 | $7.5 | -$0.52 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$3.64 | $2.2 | $2.53 | -$6.52 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$26.86 | -$25.07 | -$36.05 | -$56.96 |
| Operating activities | ||||
| Depreciation | $0.42 | $1.56 | $2.37 | $1.75 |
| Business acquisitions & disposals | $3.47 | |||
| Stock-based compensation | $0.45 | $2.24 | $4.08 | $23.54 |
| Total cash flows from operations | -$22.57 | -$27.63 | -$28.3 | -$33.17 |
| Investing activities | ||||
| Capital expenditures | $0.02 | $0.33 | -$0.07 | -$0.27 |
| Investments | $16 | -$15.76 | ||
| Total cash flows from investing | $0.02 | $3.8 | $15.93 | -$16.03 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $23.36 | $15.15 | $19.99 | $0.04 |
| Net borrowings | -$0.27 | $1.71 | -$0.34 | |
| Total cash flows from financing | $23.36 | $14.96 | $21.69 | -$0.53 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $0.81 | -$8.86 | $9.32 | -$49.73 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 5.27M |
| Revenue | $90.00K |
|---|---|
| EBITDA | -$86.09M |
| EBIT | -$87.77M |
| Net Income | -$87.77M |
| Revenue Q/Q | 844.44% |
| Revenue Y/Y | -91.21% |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 6.81 |
| Cash/Share | 2.32 |
| EPS | -$16.66 |
|---|---|
| ROA | -361.23% |
| ROE | -520.70% |
| Debt/Equity | 0.82 |
|---|---|
| Net debt/EBITDA | -0.00 |
| Current ratio | 2.86 |
| Quick ratio | 2.85 |